Cairo Pharmaceuticals (CPCI.CA) Reports 6 Months Results
15/02/2022
15/02/2022
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 82,057,367
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 67,004,062
Audit Status : Reviewed
Source : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Currency : EGP
F/S Period : from 01/07/2021 to 31/12/2021
Net Profit : 82,057,367
F/S Period: from 01/07/2020 to 31/12/2020
Net Comparative Profit : 67,004,062
Audit Status : Reviewed
Source : Cairo Pharmaceuticals